Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.

Absorption after oral administration is a requirement for almost all drug products but is a challenge for drugs with intrinsically low water solubility. Here, the weakly basic, poorly water-soluble drugs (PWSDs) itraconazole, cinnarizine, and halofantrine were converted into lipophilic ionic liquids to facilitate incorporation into lipid-based formulations and integration into lipid absorption pathways. Ionic liquids were formed via metathesis reactions of the hydrochloride salt of the PWSDs with a range of lipophilic counterions. The resultant active pharmaceutical ingredient-ionic liquids (API-ILs) were liquids or low melting point solids and either completely miscible or highly soluble in lipid based, self-emulsifying drug delivery systems (SEDDS) comprising mixtures of long or medium chain glycerides, surfactants such as Kolliphor-EL and cosolvents such as ethanol. They also readily incorporated into the colloids formed in intestinal fluids during lipid digestion. Itraconazole docusate or cinnarizine decylsulfate API-ILs were subsequently dissolved in long chain lipid SEDDS at high concentration, administered to rats and in vivo exposure assessed. The data were compared to control formulations based on the same SEDDS formulations containing the same concentrations of drug as the free base, but in this case as a suspension (since the solubility of the free base in the SEDDS was much lower than the API-ILs). For itraconazole, comparison was also made to a physical mixture of itraconazole free base and sodium docusate in the same SEDDS formulation. For both drugs plasma exposure was significantly higher for the API-IL containing formulations (2-fold for cinnarizine and 20-fold for itraconazole), when compared to the suspension formulations (or the physical mixture in the case of itraconazole) at the same dose. The liquid SEDDS formulations, made possible by the use of the API-ILs, also provide advantages in dose uniformity, capsule filling, and stability compared to similar suspension formulations. The data suggest that the formation of lipophilic ionic liquids provides a means of increasing dissolved-drug loading in lipid based formulations and thereby promoting the exposure of poorly water-soluble drugs after oral administration.

[1]  Christopher J. H. Porter,et al.  Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway , 2013, Pharmaceutical Research.

[2]  R. E. Del Sesto,et al.  Structure and magnetic behavior of transition metal based ionic liquids. , 2008, Chemical communications.

[3]  D. Macfarlane,et al.  Exploring an Anti-Crystal Engineering Approach to the Preparation of Pharmaceutically Active Ionic Liquids , 2009 .

[4]  L. Branco,et al.  Ionic Liquids as Active Pharmaceutical Ingredients , 2011, ChemMedChem.

[5]  C. Porter,et al.  A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. , 1996, Journal of pharmaceutical sciences.

[6]  Hywel D Williams,et al.  Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.

[7]  Lieven Baert,et al.  Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I. , 2003, International journal of pharmaceutics.

[8]  Kenneth R. Seddon,et al.  Ionic liquids. Green solvents for the future , 2000 .

[9]  A. Riisager,et al.  Pharmaceutically active ionic liquids with solids handling, enhanced thermal stability, and fast release. , 2012, Chemical communications.

[10]  P. Tso,et al.  A Mouse Model to Evaluate the Impact of Species, Sex, and Lipid Load on Lymphatic Drug Transport , 2013, Pharmaceutical Research.

[11]  Julia L. Shamshina,et al.  Ionic liquids in drug delivery , 2013, Expert opinion on drug delivery.

[12]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.

[13]  R. Rogers,et al.  In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid. , 2010, Physical chemistry chemical physics : PCCP.

[14]  D. Macfarlane,et al.  Crystalline vs. Ionic Liquid Salt Forms of Active Pharmaceutical Ingredients: A Position Paper , 2010, Pharmaceutical Research.

[15]  M. Freemantle.  DESIGNER SOLVENTS : IONIC LIQUIDS MAY BOOST CLEAN TECHNOLOGY DEVELOPMENT , 1998 .

[16]  C. Porter,et al.  The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs. , 2013, Molecular pharmaceutics.

[17]  Hywel D Williams,et al.  Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility. , 2014, Chemical communications.

[18]  Joon-Ho Shin,et al.  Ionic liquids to the rescue? Overcoming the ionic conductivity limitations of polymer electrolytes , 2003 .

[19]  Gadi Rothenberg,et al.  Anion and cation effects on imidazolium salt melting points: a descriptor modelling study. , 2007, Chemphyschem : a European journal of chemical physics and physical chemistry.

[20]  Masayoshi Watanabe,et al.  Belousov-Zhabotinsky reaction in protic ionic liquids. , 2012, Angewandte Chemie.

[21]  Colin W. Pouton,et al.  Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound , 2004, Pharmaceutical Research.

[22]  R. Giernoth.  Task-specific ionic liquids. , 2010, Angewandte Chemie.

[23]  A. Florence,et al.  Current-stimulated release of solutes solubilized in water-immiscible room temperature ionic liquids (RTILs) , 2010, Journal of drug targeting.

[24]  Helene Olivier-Bourbigou,et al.  Ionic liquids and catalysis: Recent progress from knowledge to applications , 2010 .

[25]  Valentino J. Stella,et al.  β‐Cyclodextrin Derivatives, SBE4‐β‐CD and HP–β‐CD, Increase the Oral Bioavailability of Cinnarizine in Beagle Dogs , 1995 .

[26]  L. Branco,et al.  Antibacterial activity of Ionic Liquids based on ampicillin against resistant bacteria , 2014 .

[27]  B. Boyd,et al.  The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug. , 2013, Journal of pharmaceutical sciences.

[28]  Julia L. Shamshina,et al.  Liquid forms of pharmaceutical co-crystals: exploring the boundaries of salt formation. , 2011, Chemical communications.

[29]  P. Wasserscheid,et al.  Ionic Liquids-New "Solutions" for Transition Metal Catalysis. , 2000, Angewandte Chemie.

[30]  J. Devoisselle,et al.  Ionogels as drug delivery system: one-step sol-gel synthesis using imidazolium ibuprofenate ionic liquid. , 2010, Chemical communications.

[31]  M. Moniruzzaman,et al.  Ionic liquid-assisted transdermal delivery of sparingly soluble drugs. , 2010, Chemical communications.

[32]  Robin D. Rogers,et al.  The third evolution of ionic liquids: active pharmaceutical ingredients , 2007 .

[33]  K. R. Seddon,et al.  Applications of ionic liquids in the chemical industry. , 2008, Chemical Society reviews.

[34]  Julia L. Shamshina,et al.  Prodrug ionic liquids: functionalizing neutral active pharmaceutical ingredients to take advantage of the ionic liquid form , 2013 .

[35]  U. Holzgrabe,et al.  Ionic Liquid Versus Prodrug Strategy to Address Formulation Challenges , 2014, Pharmaceutical Research.

[36]  Surajit Ghosh,et al.  An understanding of the modulation of photophysical properties of curcumin inside a micelle formed by an ionic liquid: a new possibility of tunable drug delivery system. , 2012, The journal of physical chemistry. B.

[37]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.